WINNERS & LOSERS: Tooru gets "significant" retail win; Petra slumps
2nd Oct 2026 10:45
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More
| Price | 270.00p on 09-10-2026 at 11:52:03 |
|---|---|
| Change | 0.00p 0% |
| Buy | 284.00p |
| Sell | 269.00p |
| Last Trade: | Sell 189.00 at 269.15p |
| Day's Volume: | 20,367 |
| Last Close: | 270.00p |
| Open: | 270.00p |
| ISIN: | GB00BMD6C023 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 184.00p - 466.00p |
| Market Capitalisation: | £30.36m |
| VWAP: | 272.63869p |
| Shares in Issue: | 11.24m |
Sector: Industrial Chemicals
Alkemy Capital. (ALK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 189 | 269.15p | Ordinary |
12:52:03 - 09-Oct-26 |
| Sell* | 3,690 | 271.125p | Ordinary |
12:35:56 - 09-Oct-26 |
| Sell* | 6,386 | 276.43p | Ordinary |
12:26:25 - 09-Oct-26 |
| Sell* | 1 | 274.45p | Ordinary |
12:01:31 - 09-Oct-26 |
| Sell* | 3 | 274.45p | Ordinary |
12:01:15 - 09-Oct-26 |
| Sell* | 56 | 274.45p | Ordinary |
11:59:26 - 09-Oct-26 |
| Sell* | 364 | 269.15p | Ordinary |
11:54:05 - 09-Oct-26 |
| Sell* | 374 | 269.15p | Ordinary |
11:45:52 - 09-Oct-26 |
| Sell* | 18 | 274.45p | Ordinary |
11:00:20 - 09-Oct-26 |
| Sell* | 25 | 274.45p | Ordinary |
10:09:57 - 09-Oct-26 |
Alkemy Capital. (ALK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th Sep 2026 7:00 am | RNS-R | Glencore visits TVL site at Billingham |
| 17th Sep 2026 7:00 am | RNS | TVL Secures £18.3m UK Government Support |
| 2nd Sep 2026 8:59 am | RNS | Loan Conversion |
| 11th Aug 2026 9:32 am | RNS | Loan Conversion |
| 8th Jul 2026 2:20 pm | RNS | TVL and E3 Lithium Refining Partnership |
| 3rd Jul 2026 2:11 pm | RNS | Result of AGM |
| 15th Jun 2026 7:01 am | RNS | Tees Valley Lithium: Publication of Impact Report |
| 15th Jun 2026 7:00 am | RNS | Issue of Shares |
| 10th Jun 2026 7:00 am | RNS | Notice of AGM |
| 28th May 2026 7:00 am | RNS | Annual Report & Financial Statements |